D-cycloserine drug
Evidence from:
primary |
all sources
Related entities (3)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| D-cycloserine | associated_with | anxiety | — | 1 |
| D-cycloserine | interacts_with | NMDA receptor | — | 1 |
| D-cycloserine | associated_with | schizophrenia | — | 1 |
Mentioned in (6)
Papers in which this entity is mentioned.
- The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. (2018)
- Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study. (2015)
- Detecting ultralow-frequency mutations by Duplex Sequencing. (2014)
- The ubiquitin-proteasome system as a critical regulator of synaptic plasticity and long-term memory formation. (2013)
- Glutamatergic transmission in schizophrenia: from basic research to clinical practice. (2012)
- Trace eyeblink conditioning increases CA1 excitability in a transient and learning-specific manner. (1996)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| d-cycloserine | drug | 5 | 10 |
| dcs | drug | 1 | 2 |